Interleukin 6, soluble interleukin 2 receptor alpha (CD25), monocyte colony-stimulating factor, and hepatocyte growth factor linked with systemic hyperinflammation, innate immunity hyperactivation, and organ damage in COVID-19 pneumonia
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interleukin 6, soluble interleukin 2 receptor alpha (CD25), monocyte colony-stimulating factor, and hepatocyte growth factor linked with systemic hyperinflammation, innate immunity hyperactivation, and organ damage in COVID-19 pneumonia
Authors
Keywords
Coronavirus, COVID-19, Pneumonia, Interleukin 6, Hepatocyte growth factor, M-CSF, Interleukin 2
Journal
CYTOKINE
Volume 140, Issue -, Pages 155438
Publisher
Elsevier BV
Online
2021-01-18
DOI
10.1016/j.cyto.2021.155438
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges
- (2020) Chih-Cheng Lai et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- (2020) Nanshan Chen et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Diagnostic Testing for Severe Acute Respiratory Syndrome–Related Coronavirus-2
- (2020) Matthew P. Cheng et al. ANNALS OF INTERNAL MEDICINE
- Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients
- (2020) Hong-Yi Zheng et al. Cellular & Molecular Immunology
- Clinical and immunological features of severe and moderate coronavirus disease 2019
- (2020) Guang Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: results from a single Italian Centre study on tocilizumab versus standard of care
- (2020) Luca Quartuccio et al. JOURNAL OF CLINICAL VIROLOGY
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
- (2020) Chaomin Wu et al. JAMA Internal Medicine
- Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients
- (2020) Yonggang Zhou et al. National Science Review
- Potential contribution of increased soluble IL-2R to lymphopenia in COVID-19 patients
- (2020) Yaguang Zhang et al. Cellular & Molecular Immunology
- Pharmaco-Immunomodulatory Therapy in COVID-19
- (2020) John G. Rizk et al. DRUGS
- Potential of regulatory T cell-based therapies in the management of severe COVID-19
- (2020) Emmanuel Stephen-Victor et al. EUROPEAN RESPIRATORY JOURNAL
- Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)
- (2020) W. Joost Wiersinga et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China
- (2020) Ying Chi et al. JOURNAL OF INFECTIOUS DISEASES
- A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression
- (2020) Samuel B. Polak et al. MODERN PATHOLOGY
- Neuropathological Features of Covid-19
- (2020) Isaac H. Solomon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting GM-CSF in COVID-19 Pneumonia: Rationale and Strategies
- (2020) Aldo Bonaventura et al. Frontiers in Immunology
- Immune Therapy, or Antiviral Therapy, or Both for COVID-19: A Systematic Review
- (2020) Fabrizio Cantini et al. DRUGS
- Cytokine profile as a prognostic tool in coronavirus disease 2019. Comment on “Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome” by Quartuccio et al. Joint Bone Spine. 2020;87:191–93
- (2020) Matheus Vieira et al. JOINT BONE SPINE
- Postmortem Findings in Italian Patients With COVID-19: A Descriptive Full Autopsy Study of Cases With and Without Comorbidities
- (2020) Laura Falasca et al. JOURNAL OF INFECTIOUS DISEASES
- SARS-CoV-2 mediated lung inflammatory responses in host: targeting the cytokine storm for therapeutic interventions
- (2020) Purva Asrani et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- An inflammatory cytokine signature predicts COVID-19 severity and survival
- (2020) Diane Marie Del Valle et al. NATURE MEDICINE
- Distinctive Effects of GM-CSF and M-CSF on Proliferation and Polarization of Two Major Pulmonary Macrophage Populations
- (2019) Christina Draijer et al. JOURNAL OF IMMUNOLOGY
- Signaling and Function of Interleukin-2 in T Lymphocytes
- (2018) Sarah H. Ross et al. Annual Review of Immunology
- Pivotal Roles of GM-CSF in Autoimmunity and Inflammation
- (2015) Aoi Shiomi et al. MEDIATORS OF INFLAMMATION
- Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF
- (2013) Martin Guilliams et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The discovery of Hepatocyte Growth Factor (HGF) and its significance for cell biology, life sciences and clinical medicine
- (2010) Toshikazu NAKAMURA et al. PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started